Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Third Harmonic Bio, Inc. - Common Stock
(NQ:
THRD
)
12.22
-0.09 (-0.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Third Harmonic Bio, Inc. - Common Stock
Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
September 10, 2024
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio to Participate in Upcoming Investor Conferences
August 26, 2024
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
May 28, 2024
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
March 28, 2024
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
March 26, 2024
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
February 26, 2024
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
January 04, 2024
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces Third Quarter 2023 Financial Results
November 09, 2023
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces Leadership Changes
October 31, 2023
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
August 31, 2023
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces Second Quarter 2023 Financial Results
August 10, 2023
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
July 25, 2023
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces First Quarter 2023 Financial Results
May 11, 2023
Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory Diseases
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
March 29, 2023
Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory Diseases
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria
December 15, 2022
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference
November 21, 2022
From
Third Harmonic Bio
Via
GlobeNewswire
Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update
November 09, 2022
From
Third Harmonic Bio
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.